Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds-Market Movers-News

Sarepta Therapeutics Inc. (SRPT) Stock: Jason Karp Is A Shareholder Again And Has A Larger Position Than Ever

Published on October 28, 2016 at 12:56 pm by Insider Monkey Staff in Hedge Funds, Market Movers, News
<< Prev
Page 4 of 8
Next >>
See All

Page 4 of 8 – SEC Filing

Item 1(a).
Name of Issuer:
Sarepta Therapeutics, Inc. (the “Issuer”)
Item 1(b).
Address of Issuer’s Principal Executive Offices:
215 First Street, Suite 415
 Cambridge, MA 02142
Item 2(a).
Name of Persons Filing:
The names of the persons filing this statement on Schedule 13G are Tourbillon Capital Partners LP (“Tourbillon Capital Partners”) and Jason H. Karp (together, the “Reporting Persons”). Mr. Karp is the Chief Executive Officer of Tourbillon Capital Partners.
Item 2(b).
Address of Principal Business Office or, if None, Residence:
The address of the principal business office of each of the Reporting Persons is 888 Seventh Avenue, 32nd Floor, New York, NY 10019.
Item 2(c).
Citizenship:
Tourbillon Capital Partners is a Delaware limited partnership. Mr. Karp is a citizen of the United States of America.
Item 2(d).
Title of Class of Securities:
Common Stock with $0.0001 par value (the “Common Stock”)
Item 2(e).
CUSIP Number:
803607100
Item 3.
If This Statement is Filed Pursuant to Rule 13d 1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
(a)
[ ]
Broker or dealer registered under Section 15 of the Exchange Act.
(b)
[ ]
Bank as defined in Section 3(a)(6) of the Exchange Act.
(c)
[ ]
Insurance company defined in Section 3(a)(19) of the Exchange Act.
(d)
[ ]
Investment company registered under Section 8 of the Investment Company Act.
(e)
[ ]
Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E).
(f)
[ ]
Employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F).
(g)
[ ]
Parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G).
(h)
[ ]
Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act.
(i)
[ ]
Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
(j)
[ ]
Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
(k)
[ ]
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).  If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

Follow Sarepta Therapeutics Inc. (NASDAQ:SRPT)
<< Prev
Page 4 of 8
Next >>
See All

Show more...Show less

Related Insider Monkey Articles
Today's Trending Stocks: Sarepta, Humana, HTG Molecular Diagnostics, and More...Sarepta Therapeutics Inc (SRPT) Stock: "Eteplirsen Approval Controversy Rages...
Why Sarepta Therapeutics, Ralph Lauren, Fifth Third Bancorp, and Two Other...Here's Why These Five Stocks Are Trading Higher Today
Why Wells Fargo, Sarepta, Delphi, UPS, and More Are Making HeadlinesRite Aid Corporation, WCI Communities & Other Stocks in Spotlight Following...